These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


351 related items for PubMed ID: 18633010

  • 1. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
    Mullen MP, Wessel DL, Thomas KC, Gauvreau K, Neufeld EJ, McGowan FX, Dinardo JA.
    Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
    [Abstract] [Full Text] [Related]

  • 2. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S, Malowsky B, Itterman T, Bagemühl J, Wessel A, Wollert HG, Warkentin TE, Greinacher A.
    Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK.
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [Abstract] [Full Text] [Related]

  • 4. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV, Bonetti L, Zennaro M, Ambrosio G, Mattioli G.
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
    Foo SY, Everett BM, Yeh RW, Criss D, Laposata M, Van Cott EM, Jang IK.
    Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
    [Abstract] [Full Text] [Related]

  • 6. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A.
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [Abstract] [Full Text] [Related]

  • 7. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.
    Selleng K, Schütt A, Selleng S, Warkentin TE, Greinacher A.
    Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391
    [Abstract] [Full Text] [Related]

  • 8. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
    Yeh RW, Everett BM, Foo SY, Dorer DJ, Laposata M, Van Cott EM, Jang IK.
    Am J Cardiol; 2006 Aug 01; 98(3):419-21. PubMed ID: 16860036
    [Abstract] [Full Text] [Related]

  • 9. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes.
    Kress DC, Aronson S, McDonald ML, Malik MI, Divgi AB, Tector AJ, Downey FX, Anderson AJ, Stone M, Clancy C.
    Ann Thorac Surg; 2007 May 01; 83(5):1737-43. PubMed ID: 17462391
    [Abstract] [Full Text] [Related]

  • 10. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
    Matsuo T, Tomaru T, Kario K, Hirokawa T, HIT Research Group of Japan.
    Thromb Res; 2005 May 01; 115(6):475-81. PubMed ID: 15792678
    [Abstract] [Full Text] [Related]

  • 11. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery.
    Kerendi F, Thourani VH, Puskas JD, Kilgo PD, Osgood M, Guyton RA, Lattouf OM.
    Ann Thorac Surg; 2007 Nov 01; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061
    [Abstract] [Full Text] [Related]

  • 12. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test.
    Dellaria SM, Greilich PE, Sarode R.
    Anesth Analg; 2008 Aug 01; 107(2):379-81. PubMed ID: 18633011
    [Abstract] [Full Text] [Related]

  • 13. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery.
    Bennett-Guerrero E, Slaughter TF, White WD, Welsby IJ, Greenberg CS, El-Moalem H, Ortel TL.
    J Thorac Cardiovasc Surg; 2005 Dec 01; 130(6):1567-72. PubMed ID: 16308000
    [Abstract] [Full Text] [Related]

  • 14. Serum antibodies to the heparin/platelet factor 4 complex are an independent predictor of thrombotic complications following pediatric fontan surgery.
    Zhang R, Huang Y, Zhang M, Bai J, Liu J.
    Clin Appl Thromb Hemost; 2012 Sep 01; 18(5):448-52. PubMed ID: 22679243
    [Abstract] [Full Text] [Related]

  • 15. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M, Saxena R, Adiguzel C, Fareed J.
    Semin Thromb Hemost; 2009 Apr 01; 35(3):337-43. PubMed ID: 19452409
    [Abstract] [Full Text] [Related]

  • 16. Formation of anti-platelet factor 4/heparin antibodies after cardiac surgery: influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status.
    Paparella D, Scrascia G, Galeone A, Coviello M, Cappabianca G, Venneri MT, Favoino B, Quaranta M, Schinosa Lde L, Warkentin TE.
    J Thorac Cardiovasc Surg; 2008 Dec 01; 136(6):1456-63. PubMed ID: 19114189
    [Abstract] [Full Text] [Related]

  • 17. Low prevalence of heparin-induced thrombocytopenia after cardiac surgery in Thai patients.
    Boonyawat K, Angchaisuksiri P, Aryurachai K, Chaiyaroj S, Ahmadi Z, Chong BH.
    Thromb Res; 2014 Nov 01; 134(5):957-62. PubMed ID: 25204999
    [Abstract] [Full Text] [Related]

  • 18. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM, Foroulis CN, Vassili MI, Matsouka P, Astras GM, Kantidakis GH, Iliopoulou E, Melissari EN.
    J Thorac Cardiovasc Surg; 2004 Feb 01; 127(2):548-54. PubMed ID: 14762367
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C, Cini M, Pili C, Boggian O, Frascaro M, Palareti G.
    Thromb Haemost; 2010 Aug 01; 104(2):402-9. PubMed ID: 20539902
    [Abstract] [Full Text] [Related]

  • 20. Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.
    Demir M, Duran E, Yigitbasi O, Vural O, Kurum T, Yuksel M, Turgut B, Walenga JM, Fareed J.
    Clin Appl Thromb Hemost; 2007 Jul 01; 13(3):279-84. PubMed ID: 17636189
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.